Mid-Term Outcomes and Aneurysm Sac Dynamics Following Fenestrated Endovascular Aneurysm Repair after Previous Endovascular Aneurysm Repair.

Failed endovascular aneurysm repair Failure to rescue Fenestrated endovascular aneurysm repair Five year aortic related procedures Sac dynamics

Journal

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
ISSN: 1532-2165
Titre abrégé: Eur J Vasc Endovasc Surg
Pays: England
ID NLM: 9512728

Informations de publication

Date de publication:
30 Jan 2024
Historique:
received: 14 07 2023
revised: 19 12 2023
accepted: 23 01 2024
medline: 2 2 2024
pubmed: 2 2 2024
entrez: 1 2 2024
Statut: aheadofprint

Résumé

Fenestrated endovascular aneurysm repair (FEVAR) represents a feasible option for aortic repair after endovascular aneurysm repair (EVAR), due to improved peri-operative outcomes compared with open conversion. However, little is known regarding the durability of FEVAR as treatment of failed EVARs. Since aneurysm sac evolution is an important marker for success after aneurysm repair, the aim of the study was to examine mid-term outcomes and aneurysm sac dynamics of FEVAR after prior EVAR. Patients undergoing FEVAR for complex abdominal aortic aneurysms from 2008 to 2021 at two hospitals in The Netherlands were included. Patients were categorised into primary FEVAR and FEVAR after EVAR. Outcomes included five year mortality, one year aneurysm sac dynamics (regression/stable/expansion), sac dynamics over time, and five year aortic related procedures. Analyses were done using Kaplan-Meier methods, multivariable Cox regression analysis, chi-square tests, and linear mixed effect models. In total, 196 patients with FEVAR were identified, of whom 27% (n = 53) had a prior EVAR. Patients with prior EVAR were significantly older (78 ± 6.7 years vs. 73 ± 5.9 years, p < .001). There were no significant differences in mortality. FEVAR after EVAR was associated with higher risk of aortic related procedures within five years (hazard ratio [HR] 2.6; 95% confidence interval [CI] 1.1 - 6.5, p = .037). Sac dynamics were assessed in 154 patients with available imaging. Patients with a prior EVAR showed lower rates of sac regression and higher rates of sac expansion at one year compared with primary FEVAR (sac expansion 48%, n = 21/44, vs. 8%, n = 9/110, p < .001)). Sac dynamics over time showed similar results, sac growth for FEVAR after EVAR, and sac shrinkage for primary FEVAR (p < .001). FEVAR after EVAR showed high rates of sac expansion and needed more secondary procedures than patients with primary FEVAR, although this did not affect mid-term survival. Future studies will have to assess whether FEVAR after EVAR is a valid intervention, and the underlying process that drives aneurysm sac growth following successful FEVAR after EVAR.

Identifiants

pubmed: 38301871
pii: S1078-5884(24)00097-2
doi: 10.1016/j.ejvs.2024.01.070
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved.

Auteurs

Titia A L Sulzer (TAL)

Department of Vascular Surgery, Erasmus University Medical Centre, Rotterdam, The Netherlands; The University of Texas Health Science Center at Houston, McGovern Medical School, Houston, TX, USA. Electronic address: titiasulzer@gmail.com.

Jorg L de Bruin (JL)

Department of Vascular Surgery, Erasmus University Medical Centre, Rotterdam, The Netherlands.

Vinamr Rastogi (V)

Department of Vascular Surgery, Erasmus University Medical Centre, Rotterdam, The Netherlands.

Gert Jan Boer (GJ)

Department of Vascular Surgery, Maasstad Hospital Rotterdam, The Netherlands.

Thomas Mesnard (T)

The University of Texas Health Science Center at Houston, McGovern Medical School, Houston, TX, USA.

Bram Fioole (B)

Department of Vascular Surgery, Maasstad Hospital Rotterdam, The Netherlands.

Marie Josee van Rijn (MJ)

Department of Vascular Surgery, Erasmus University Medical Centre, Rotterdam, The Netherlands.

Marc L Schermerhorn (ML)

Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Gustavo S Oderich (GS)

The University of Texas Health Science Center at Houston, McGovern Medical School, Houston, TX, USA.

Hence J M Verhagen (HJM)

Department of Vascular Surgery, Erasmus University Medical Centre, Rotterdam, The Netherlands.

Classifications MeSH